The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units?
Condition(s) studied
Study summary
Here, the investigators propose to study host responses to reduced microbiome complexity driven by treatment with broad spectrum antibiotics in patients with severe infections or sepsis. The proposal aims to combine holistic approaches with emerging experimental technologies to investigate the complex interactions between the gut microbiota and its host and assess the impact of specific bacterial communities on longevity and stress responses. A strong focus of this study will also be placed on microbiome dysbiosis and secondary impacts on short- and long-term brain dysfunction using clinical, laboratory and imaging procedures.
Eligibility
Primary outcome measure(s)
- Number of patients with brain dysfunction — From enrollment to day 180
Patients from all three groups will be assessed for microbiome dysbiosis (e.g. shotgun metagenomics), and for brain dysfunction (e.g. CAM-ICU, ICDSC, MoCa, MMST, neuropsychiatric examination, MRI).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Jena | Jena | Thuringia | Recruiting |
More Jena University Hospital trials in Germany
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06749483 on ClinicalTrials.gov ↗ ← All trials in Germany